New England Capital Financial Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
NP
DADC
TWC
BEI
HFM
AFA
SA
IA
HFP
New England Capital Financial Advisors's FBT Position: Q2 2026 in Review
New England Capital Financial Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 97 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #187.
New England Capital Financial Advisors first reported a position in FBT in Q4 2022 and has held it in 15 quarters since. 109 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- New England Capital Financial Advisors held 97 shares of First Trust NYSE Arca Biotechnology Index Fund worth $24K as of Q2 2026.
- New England Capital Financial Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #187 holding.
- New England Capital Financial Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 15 quarters since.
- 109 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.